The Inspire ANTI SNORING Implant is really a medical device that is implanted in to the body for the treating snoring and obstructive anti snoring (OSA) syndrome.
Obstructive ANTI SNORING Syndrome
Obstructive sleep apnea syndrome is really a disease due to relapsing episodes of anti snoring. That is a condition where breathing stops for a lot more than 10 seconds, during which oxygen saturation in the blood is reduced by more than 4%.
OSA syndrome occurs while asleep, when the muscles of upper airways relax, evoking the obstruction of the respiratory system. This leads to deterioration of blood oxygenation and provokes short unconscious wake-up episodes through the entire night. An unhealthy pattern of sleep places stress on the body, causing increased blood circulation pressure and development of severe diseases. The diseases caused by OSA can be physical, such as for example hypertension, myocardium infarction and stroke. They might also be mental, including depression, chronic fatigue syndrome, lack of memory and concentration.
Before any treatment, a sleep study or perhaps a polysomnography is needed. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during 1 hour of sleep and determines the severity of the condition. The apnea index is considered significant if there are a lot more than 20 apnea episodes each hour, whatever the presence or lack of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy isn’t for everyone as many people find it uncomfortable to sleep with the mask on the facial skin and the machine itself can be loud, especially since it commonly sits close to the head. Only 25% of patients may use CPAP-therapy for a long period of time.
Therefore, recently Inspire Medical Systems Inc. has think of a very effective solution with the Inspire ANTI SNORING Implant.
How The Inspire ANTI SNORING Implant Works
The Inspire ANTI SNORING Implant is really a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately a decade.
The main unit of the device is placed beneath the skin, on the front right side of the chest and it monitors the phase of breathing. The other electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens top of the airways and allows the tongue to stick out, and helps maintain the airways open during sleep.
In addition to the two electrodes, this device also contains a handy small remote switch, which actually turns on these devices before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating through the active phase of the day, when a person needs physiological narrowing of the larynx and tongue movements for these procedures.
The patient may feel light involuntary contractions of the larynx, or tongue movements during initial usage of these devices. These movements usually do not cause pain, instead just a minor discomfort. These unpleasant effects disappear after the first few uses of the device.
Generally, the implant should be checked 1 or 2 2 times per year. However, according to the situation, an Inspire therapy-trained doctor may consult patients more or less often.
The Inspire ANTI SNORING Implant is only suitable for:
Patients who are more than 22 years old.
Patients who’ve been diagnosed with moderate or severe obstructive anti snoring syndrome.
Patients having an apnea index in the range of 20 to 65.
Patients who are uncomfortable with using CPAP therapy or did not have the desired effect.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
A person with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire Sleep Apnea Implant may potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive anti snoring syndrome. A report by Dr. Ryan J. et al. shows that after implantation of the Inspire Sleep Apnea Implant, snoring is greatly decreased. A share of “no” or “soft” snoring changed from 22% at start of the treatment to 88% at 12 months and 91% at two years following the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the study reported a nightly use of this therapy for five years. ufabet Therefore, it is evident that this method is highly effective and easy to use!